Issue 8/2017
Content (9 Articles)
Open Access
Letters to the Editor
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Comment
Hannah Cohen, Beverley J. Hunt, Maria Efthymiou, Ian J. Mackie, Munther Khamashta, David A. Isenberg
Letters to the Editor
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to Comment
Virginie Dufrost, Jessie Risse, Denis Wahl, Stéphane Zuily
Antiphospholipid Syndrome (S Zuily, Section Editor)
How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores
Kenji Oku, Olga Amengual, Shinsuke Yasuda, Tatsuya Atsumi
Osteoarthritis (M Goldring, Section Editor)
Recent Advances in Tissue Engineering Strategies for the Treatment of Joint Damage
Makeda K. Stephenson, Ashley L. Farris, Warren L. Grayson
Osteoarthritis (M Goldring, Section Editor)
Innate Immune Responses and Osteoarthritis
Evangelia Kalaitzoglou, Timothy M. Griffin, Mary Beth Humphrey
Osteoarthritis (M Goldring, Section Editor)
Contribution of Circulatory Disturbances in Subchondral Bone to the Pathophysiology of Osteoarthritis
Roy K. Aaron, Jennifer Racine, Jonathan P. Dyke
Systemic Lupus Erythematosus (G Tsokos, Section Editor)
New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus
Marc Scherlinger, Vanja Sisirak, Christophe Richez, Estibaliz Lazaro, Pierre Duffau, Patrick Blanco